Financial MarketsInvesting.comWed, Sep 3, 2025, 7:47 PMPositive

Oppenheimer maintains Olema stock rating, sees Pfizer deal as strategic

Oppenheimer has reaffirmed its stock rating for Olema, viewing the recent Pfizer deal as a strategic move that could benefit the company.

WPN Brief

Oppenheimer has reaffirmed its stock rating for Olema, viewing the recent Pfizer deal as a strategic move that could benefit the company.
Ask WPN AI